Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Ethical Standards I

Ethical Standards I

The American Nurses Association (ANA) created and implemented the first nationally accepted Code of Ethics for Nurses with Interpretive Statements. The Code of Ethics is a living document regularly updated by the ANA and establishes an ethical standard that is non-negotiable for nurses in all roles and settings.
The Code of Ethics provisions outline the nurse's duty to the patient, the healthcare team, the profession, and society. The Code's fundamental principles include advocacy,...

Ethical Standards II

Ethical Standards II

Ethical standards are the backbone of nursing practice, guiding nurses as they interact with patients, families, and colleagues. These standards are crucial for providing safe, empathetic care centered on the patient's needs.
Nurses are entrusted with upholding various ethical principles and standards. Nurses forge solid therapeutic relationships using trust, empathy, autonomy, confidentiality, and professional competence.
Confidentiality is crucial, embodying respect for individual privacy...

Ethical Issues

Ethical Issues

Nurses are essential in patient care, upholding the ethical principles of their profession and effectively navigating ethical dilemmas. Neglecting ethical issues can lead to inadequate patient care, compromised therapeutic relationships, and moral distress among healthcare workers.
Ethical Concerns in Healthcare:

Legal Guidelines for Documentation

Legal Guidelines for Documentation

The legal guidelines for nursing documentation are essential for ensuring accurate, professional, and ethical recording of patient care. The guidelines are discussed here:

Ethics in Research

Ethics in Research

Today, scientists agree that good research is ethical in nature and is guided by a basic respect for human dignity and safety. However, this has not always been the case. Modern researchers must demonstrate that the research they perform is ethically sound.

Methods of Documentation VII: EMR

Methods of Documentation VII: EMR

Electronic Medical Records (EMRs) primarily center around electronically documenting patients' health information within a single healthcare organization or practice. They contain essential clinical data related to a patient's medical history, diagnoses, medications, treatment plans, lab results, and other pertinent information relevant to the specific encounter or episode of care. EMRs are designed to streamline documentation and workflow processes within individual healthcare...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Effects of primary or secondary prevention with vitamin A supplementation on clinically important outcomes: a systematic review of randomised clinical trials with meta-analysis and trial sequential analysis.

BMJ open·2024

Same author

WHO Essential Medicines List and methylphenidate for ADHD in children and adolescents.

The lancet. Psychiatry·2024

Same author

Concentrations, Number of Doses, and Formulations of Aluminium Adjuvants in Vaccines: A Systematic Review with Meta-Analysis and Trial Sequential Analysis of Randomized Clinical Trials.

Vaccines·2023

Same author

Ugeskrift for laeger·2023

Same author

Detailed statistical analysis plan for a secondary Bayesian analysis of the SafeBoosC-III trial: a multinational, randomised clinical trial assessing treatment guided by cerebral oximetry monitoring versus usual care in extremely preterm infants.

Trials·2023

Same author

The effects of cerebral oximetry in mechanically ventilated newborns: a protocol for the SafeBoosC-IIIv randomised clinical trial.

Trials·2023

Same journal

Risk reclassification and implementation challenges in the 2026 AHA/ACC pulmonary embolism guideline.

European journal of internal medicine·2026

Same journal

Recurrent Pericarditis, Hydroxychloroquine, and the Unrecognized Risk of Myasthenia Gravis.

European journal of internal medicine·2026

Same journal

Aldosterone synthase inhibitors in uncontrolled and resistant hypertension: promise, pitfalls, and unanswered questions.

European journal of internal medicine·2026

Same journal

Obstructive sleep apnea syndrome as the missing piece in the puzzle of cardiovascular-kidney-liver-metabolic syndrome.

European journal of internal medicine·2026

Same journal

Testosterone therapy in chronic kidney disease patients: an underutilized resource.

European journal of internal medicine·2026

Same journal

Considerations regarding the diagnosis of short telomere syndrome in a patient with opportunistic infections.

European journal of internal medicine·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Apr 24, 2026

gP2S, an Information Management System for CryoEM Experiments

gP2S, an Information Management System for CryoEM Experiments

Published on: June 10, 2021

Fostering EMA's transparency policy.

Rita Banzi¹, Vittorio Bertele'¹, Jacques Demotes-Mainard²

¹IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, via Giuseppe La Masa 19, 20156 Milano, Italy.

European Journal of Internal Medicine

|September 10, 2014

Summary

This summary is machine-generated.

The European Medicines Agency is improving clinical trial data access. This initiative supports transparency and requires stakeholder collaboration for effective and secure data sharing practices.

Keywords:

Clinical trials Drug regulation Ethics Independent clinical research Individual-patient data Transparency

More Related Videos

Scalable Solution-processed Fabrication Strategy for High-performance, Flexible, Transparent Electrodes with Embedded Metal Mesh

Scalable Solution-processed Fabrication Strategy for High-performance, Flexible, Transparent Electrodes with Embedded Metal Mesh

Published on: June 23, 2017

Author Spotlight: Advancements in Correlative Light and Electron Microscopy with Fluorescent Protein Preservation

Author Spotlight: Advancements in Correlative Light and Electron Microscopy with Fluorescent Protein Preservation

Published on: January 12, 2024

Related Experiment Videos

Last Updated: Apr 24, 2026

gP2S, an Information Management System for CryoEM Experiments

gP2S, an Information Management System for CryoEM Experiments

Published on: June 10, 2021

Scalable Solution-processed Fabrication Strategy for High-performance, Flexible, Transparent Electrodes with Embedded Metal Mesh

Scalable Solution-processed Fabrication Strategy for High-performance, Flexible, Transparent Electrodes with Embedded Metal Mesh

Published on: June 23, 2017

Author Spotlight: Advancements in Correlative Light and Electron Microscopy with Fluorescent Protein Preservation

Author Spotlight: Advancements in Correlative Light and Electron Microscopy with Fluorescent Protein Preservation

Published on: January 12, 2024

Area of Science:

Pharmacovigilance and Drug Safety
Regulatory Science
Clinical Research Informatics

Background:

The European Medicines Agency (EMA) has initiated a policy for accessing clinical trial data.
This policy has sparked ongoing discussions among researchers, industry professionals, and the public.
Regulatory bodies are key to managing and standardizing clinical trial data repositories.

Purpose of the Study:

To highlight the significance of the EMA's new clinical trial data access policy.
To advocate for stakeholder engagement and support for the EMA's data sharing initiative.
To propose recommendations for optimizing clinical trial data sharing.

Main Methods:

Analysis of the EMA's draft policy on clinical trial data access.
Review of the ongoing debate surrounding data sharing.
Formulation of suggestions based on clinical research expertise.

Main Results:

The EMA's policy represents a significant advancement in data accessibility.
Stakeholder engagement is crucial for the policy's success.
Standardized practices are needed for secure and effective data sharing.

Conclusions:

The EMA's move towards open clinical trial data access is a positive development.
Collaboration among academia, industry, and regulatory bodies is essential.
Recommendations are provided to ensure complete, safe, and effective data sharing.